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Summary
The increasing number of diagnosed cases of inherited
thrombocytopenias, owing to the routine practice of in-
cluding platelet counts in blood tests, suggests that this
condition is not so rare as expected. In the majority of
cases, the molecular basis of the disease is unknown,
although the defect is likely to affect thrombocytopoiesis
and regulation of the normal platelet count. Here we
report a genomewide search in a large Italian family
affected by autosomal dominant thrombocytopenia. Pa-
tients showed a moderate thrombocytopenia with min-
imal symptoms characterized by normocellular bone
marrow, normal medium platelet volume, and positive
aggregation tests. Microsatellite analysis demonstrated
that the disease locus (THC2) is linked to chromosome
10p11.1-12, within a candidate region of 6 cM between
markers D10S586 and D19S1639. A maximum LOD
score of 8.12 at recombination fraction .00 was obtained
with the microsatellite D10S588. These data localized
the first locus of an autosomal dominant thrombocy-
topenia, and the subsequent identification of the gene
will provide new insight into the basic mechanism of
megakaryocytopoiesis disorders.
Introduction
Inherited thrombocytopenias represent a heterogeneous
group of disorders (Dowton et al. 1985). Different cri-
teria have been suggested to classify the different forms,
such as platelet volume, number and morphology of
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megakaryocytes, or inheritance pattern. X-linked, au-
tosomal dominant, and recessive thrombocytopenias
have been reported. In addition to the clinical syndromes
in which thrombocytopenia is associated with other ab-
normalities, such as Fanconi anemia, Wiskott-Aldrich
syndrome, and thrombocytopenia with absent-radius
syndrome (Derry et al. 1994; Villa et al. 1995; Savoia
et al. 1996; Strippoli et al. 1998), thrombocytopenia can
be the only clinical finding in many families. In these
cases, some thrombocytopenias are characterized by a
hypomegakaryocytic bone marrow with mono- or mul-
tilineage involvement, whereas others have normal
megakaryocyte count. On the basis of the medium plate-
let volume (MPV), nonsyndromic forms could further
be classified as macro-, micro-, and normothrombocy-
topenia (Najean and Lecompte 1995; Bellucci 1997).
The prevalence of nonsyndromic thrombocytopenias
is unknown. However, the incidence might be high, be-
cause of the existence of clinically asymptomatic indi-
viduals. Indeed, the recent widespread use of automated
cell counters has led to an increase in the diagnosis of
thrombocytopenia. In some patients, thrombocytopenia
is not discovered until adulthood, and a mistaken di-
agnosis is often made, resulting in an inappropriate treat-
ment and splenectomy (Majado et al. 1992).
Moderate thrombocytopenia with minimal symp-
toms, normal platelet morphology, and normal marrow
megakaryocytes are characteristics in most patients with
autosomal dominant traits (MIM 188000 [Bithell et al.
1965; Najean and Lecompte 1990; Fabris et al. 1997]).
We have recently described a large family in which 17
patients had similar features. Linkage analysis excluded
thrombopoietin (TPO) and its receptor c-mpl as can-
didate genes, as well as another two candidate loci on
chromosome 11 and 21 (Iolascon et al., in press).
The results of a genomewide search performed in this
family showed that the thrombocytopenia locus of this
family (THC2) is located on chromosome 10p11.2-12
in an interval between microsatellites D10S586 and
D10S1639.
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Table 1
Two-Point LOD Scores between Chromosome 10p Markers and Disease Locus TCH2
LOCUS
LOD SCORE AT v =
MAXIMUM
LOD SCORE
MAXIMUM
v.00 .01 .05 .10 .20 .30 .40
D10S548  4.00 4.92 4.89 4.11 2.90 1.37 4.96 .07
D10S595  4.00 4.92 4.89 4.11 2.90 1.37 4.96 .07
D10S1660  1.25 1.74 1.76 1.45 .97 .43 1.78 .08
D10S586  .96 1.46 1.51 1.27 .86 .40 1.51 .09
D10S572 2.70 2.66 2.46 2.21 1.68 1.10 .51 2.70 .00
D10S1775 6.62 6.51 6.08 5.52 4.29 2.90 1.33 6.62 .00
D10S197 3.91 3.84 3.57 3.22 2.45 1.59 .62 3.91 .00
D10S1771 7.52 7.40 6.92 6.29 4.90 3.34 1.57 7.52 .00
D10S588 8.12 8.00 7.48 6.80 5.31 3.63 1.73 8.12 .00
D10S1639  4.52 4.80 4.57 3.69 2.53 1.15 4.81 .04
D10S213  6.00 6.20 5.84 4.71 3.27 1.55 6.23 .03
D10S208  2.41 3.44 3.56 3.13 2.29 1.16 3.57 .90
Material and Methods
Genotyping
Genomic DNA from peripheral-blood lymphocytes of
36 family members, including 17 affected individuals,
12 unaffected bloodline relatives, and 7 spouses, was
used for genetic analysis (fig. 1). Clinical data on the
patients have been described by Iolascon et al. (in press).
Genotyping was performed by a DNA sequencer ap-
paratus (ABI 377A) and the ABI PRISM Linkage Map-
ping Set, version 2 (PE Biosystems). This set comprises
400 fluorescently labeled markers that define a 10-cM-
resolution map in humans. PCR conditions were the
same as those specified in the manufacturer’s instruc-
tions. DNA fragment–sizing analysis was performed by
GENESCAN and GENOTYPER software.
Linkage Analysis
Classic two-point LOD-score analysis was done in this
pedigree, under the assumption of autosomal dominant
inheritance and complete genetic penetrance. All of the
individuals with a platelet value ! /liter were111.00# 10
classified as affected. The MLINK program included in
the LINKAGE package was used to perform linkage
analysis (Lathrop et al. 1984).
Haplotype Reconstruction
To better characterize the possible meiotic recombi-
nants and to define the critical region of the disease lo-
cus, we performed haplotype analysis. Five microsatel-
lites (D10S595, D10S1660, D10S586, D10S572, and
D10S1775, from Ge´ne´thon), which are known to map
between D10S548 and D10S197 of the ABI PRISM
Linkage Mapping Set, and another four microsatellites
(D10S1771, D10S588, D10S1639, and D10S213, from
Ge´ne´thon), which span the interval between D10S197
and D10S208 and which also are in the ABI PRISM
Linkage Mapping Set, were synthesized by a DNA syn-
thesizer (Applied Biosystems). All the forward primers
were labeled with 6-FAM or HEX fluorescent amidites
and were purified with OPC columns (ABI/PE Biosys-
tems). PCR was performed under standard conditions,
and amplification products were analyzed in an ABI
377A automated sequencer.
Results
Genomewide Search
We previously have described the clinical, biological,
and molecular findings of an autosomal dominant
thrombocytopenia in a large Italian family (Iolascon et
al., in press). After excluding a linkage to candidate loci
(Iolascon et al., in press), we considered this pedigree
for genomewide linkage mapping. A prescreening was
done only with the 17 affected DNA samples, by use of
the ABI PRISM Linkage Mapping Set markers. Micro-
satellite mapping excluded most of the genome and iden-
tified two loci, on chromosomes 10 and 11, because of
the fact that all the patients shared the same allele. These
markers were then tested in all pedigree members, and
the candidate locus on chromosome 11 was clearly
excluded from linkage (data not shown). Under the
assumption of complete genetic penetrance, marker
D10S197 on chromosome 10p gave a maximum two-
point LOD score of 3.91 at recombination fraction (v)
.00 (table 1). The two flanking microsatellites, D10S548
and D10S208, showed linkage to the thrombocytopenia
locus, with maximum LOD score of 4.96 and 3.57 at
and .09, respectively (table 1).v = .07
Linkage Analysis
D10S548 and D10S208 defined the THC2 locus in
a region of ∼17 cM (fig. 2). The marker density was
further increased, with nine additional microsatellites
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Figure 2 Schematic representation of a partial linkage map of
12 microsatellite markers located on 10p11.2-12. The mapping order
and genetic distances (in cM) were obtained from the Whitehead In-
stitute/MIT Genome Sequencing Project. The boldface segment de-
notes the linked interval determined by haplotype analysis.
that were tested on all pedigree members. Markers
D10S588 and D10S1771 yielded the maximum two-
point LOD scores: 8.12 and 7.52 ( ), respectivelyv = 0
(table 1). Haplotype analysis was performed on the
basis of the microsatellite order tel-D10S548-
D10S595-D10S1660-D10S586-D10S572-D10S1775-
D10S197-D10S1771-D10S588-D10S1639-D10S213-
D10S208-cen, deduced from data from the Whitehead
Institute/MIT Genome Sequencing Project (figs. 1 and
2). A centromeric recombination was evident between
D10S588 and D10S1639, in individual III-14. In IV-
4, a crossing-over between D10S586 and D10S572
established the distal limit of the disease region, at
D10S586. Another recombinational event was ob-
served between markers D10S595 and D10S1775 in
individual III-19. In this case, however, microsatellites
D10S1660, D10S586, and D10S572 were not infor-
mative, since the patient’s mother was homozygous
at all three loci. Taken together, the recombinations
defined the candidate region at an interval of ∼6 cM
flanked by microsatellites D10S586 and D10S1639
(fig. 2).
Discussion
Inherited thrombocytopenias are heterogeneous syn-
dromes. In many cases, the only finding is an increased
platelet volume, inherited as an autosomal dominant
trait, without other hematologic abnormalities. We have
recently described a large pedigree carrying an autoso-
mal dominant thrombocytopenia characterized by nor-
mal MPV (Iolascon et al., in press). The megakaryocytes
were morphologically normal and had not increased in
number. Platelets were functionally active, suggesting
that the basic mechanism of this form could be an ab-
normal platelet release from bone marrow. The family
was sufficiently large to allow a genomewide search and
localization of the THC2 locus on the short arm of
chromosome 10 (10p11.2-12), between microsatellites
D10S586 and D10S1639.
Another two different forms of thrombocytopenia
have been mapped, to chromosomes 11q23.3-qter and
21q22.1-22.2 (Breton-Gorius et al. 1995; Ho et al.
1996). Microsatellites in these candidate regions were
not initially found in linkage with the THC2 locus (Io-
lascon et al., in press). The exclusion was consistent with
the clinical and hematologic features of patients in each
family, compared with those of thrombocytopenic in-
dividuals reported in the present study. The first form
represented a new entity of congenital thrombocytope-
nia, associated with a partial deletion of the long arm
of chromosome 11, the presence of giant a-granules in
a subpopulation of platelets, an increased number of
bone-marrow megakaryocytes, including numerous mi-
cromegakaryocytes, and a normal platelet life span
(Breton-Gorius et al. 1995). The other was an autosomal
dominant platelet disorder with a striking propensity
toward development of hematologic malignancies (Ho
et al. 1996). All patients had laboratory abnormalities,
including shortened platelet life span, large platelets, in-
creased number of bone-marrow megakaryocytes, neu-
trophil nuclear hyperpigmentation, and eosinophilia.
The chromosomal region 10p11.2-12 between mark-
ers D10S586 and D10S1639 is physically covered by a
YAC contig (WC10.1; Whitehead Institute/MIT Ge-
nome Sequencing Project). On the basis of this map, the
size of this interval between markers D10S586 and
D10S1639 was estimated to be 6 cM. This interval con-
tains only two known genes (e3B1 [for an eps8-binding
protein] andGAD2 [for glutamate decarboxylase 2]) but
several expressed sequence tags, some of which, on the
basis of their homologies and expression, could repre-
sent candidate genes (National Center for Biotechnology
Information).
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The localization of the THC2 locus represents an im-
portant step in the understanding of the genetic basis of
inherited thrombocytopenias. New families will be
tested for linkage to the chromosome 10p. Pedigrees that
do not show linkage to this locus could then be used
for a further genomewide search. The search for the gene
through the candidate-gene approach could add clues
to the understanding, at the functional level, of the mo-
lecular defects causing platelet reduction in affected
individuals.
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